Teresa Leezer of RhinoCyte, Inc.
joined us for World Orphan Drug Congress USA 2015 to present about '
Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases'
Download the presentation here to understand more about:
-
RhinoCyte key product attributes
-
Investigational New Drug (IND) Submission in Spinal Cord Injury
-
Phase I/II Multi-center Trial
-
RhinoCyte Financial Status
-
Value Proposition
...and
much
more!
Get your copy here!
To find out more about how
RhinoCyte is working to commercialize autologous neural stem cell therapies for neurodengerative diseases
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.